Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Exforge“
Suchtreffer
Begriffe & Kennungen
Exforge HCT · 4.8 · 13 Summary of the safety profile
Eintrag öffnenExforge HCT · 4.8 · 14 Metabolism and Anorexia Uncommon -- -- -- nutrition Hypercalcaemia Uncommon -- -- Rare disorders Hyperglyca
Eintrag öffnenExforge HCT · 4.8 · 15 Respiratory, Cough Uncommon Very rare Uncommon -- thoracic and Dyspnoea Uncommon Uncommon -- -- mediastinal
Eintrag öffnenExforge HCT · 4.8 · 16 Musculoskeletal Arthralgia -- Uncommon -- -- and connective Back pain Uncommon Uncommon -- -- tissue disord
Eintrag öffnenExforge HCT · 4.8 · 17 professionals are asked to report any suspected adverse reactions via the national reporting system listed
Eintrag öffnenExforge HCT · 4.8 · Description of selected adverse reactions
Eintrag öffnenExforge HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Exf
Eintrag öffnenExforge HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenExforge HCT · 4.8 · MedDRA Adverse reactions Frequency System Organ Exforge Amlodipine Valsartan HCT Class HCT Neoplasms Non-melan
Eintrag öffnenExforge HCT · 4.8 · Non-melanoma skin cancer: based on available data from epidemiological studies, cumulative dose-dependent asso
Eintrag öffnenExforge HCT · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenExforge HCT · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenExforge HCT · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenExforge HCT · 4.8 · The following adverse reactions, listed by MedDRA System Organ Class and frequency, concern Exforge HCT (amlod
Eintrag öffnenExforge HCT · 4.8 · The safety of Exforge HCT has been evaluated at its maximum dose of 10 mg/320 mg/25 mg in one controlled short
Eintrag öffnenExforge HCT · 4.8 · The safety profile of Exforge HCT presented below is based on clinical studies performed with Exforge HCT and
Eintrag öffnenExforge · 4.1 Therapeutic indications · 1
Eintrag öffnenExforge · 4.3 Contraindications · 1
Eintrag öffnenExforge · 4.3 · • Hypersensitivity to the active substances, to dihydropyridine derivatives, or to any of the excipients liste
Eintrag öffnenExforge · 4.4 Special warnings and precautions for use · 1
Eintrag öffnen